Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation—A Meta-Regression of Randomized Trials

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Therapeutics

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MJT.0000000000000048PMID 25036814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

  2013cited by this paper
• n-3 fatty acids in patients with multiple cardiovascular risk factors.

  2013cited by this paper
• Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.

  2012cited by this paper
• Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.

  2012cited by this paper
• n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

  2012cited by this paper
• The Big Ones That Got Away: Omega-3 Meta-analysis Flawed by Excluding the Biggest Fish Oil Trials-Reply.

  2012cited by this paper
• Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis

  2012cited by this paper
• Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

  2012cited by this paper
• Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: A Randomized Controlled Trial

  2011cited by this paper
• Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

  2011cited by this paper
• Effects of Omega-3 Fatty Acid for Sudden Cardiac Death Prevention in Patients with Cardiovascular Disease: A Contemporary Meta-Analysis of Randomized, Controlled Trials

  2011cited by this paper
• n-3 fatty acids and cardiovascular events after myocardial infarction.

  2010cited by this paper
• Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

  2010cited by this paper
• A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk

  2010cited by this paper
• OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction

  2010cited by this paper
• Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials

  2010cited by this paper
• Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

  2010cited by this paper
• Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

  2009cited by this paper
• Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials

  2009cited by this paper
• Is Antioxidant and n–3 Supplementation Able to Improve Functional Status in Poststroke Patients? Results from the Nutristroke Trial

  2009cited by this paper
• Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review

  2009cited by this paper
• Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias

  2008cited by this paper
• Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

  2007cited by this paper
• Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial.

  2006cited by this paper
• N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial.

  2006cited by this paper
• Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake

  2005cited by this paper
• Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.

  2005cited by this paper
• Beneficial Cardiovascular Pleiotropic Effects of Statins

  2004cited by this paper
• N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

  2002cited by this paper
• Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

  2002cited by this paper
• An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

  2001cited by this paper
• Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol.

  2001cited by this paper
• A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis

  2000cited by this paper
• n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study

  1999cited by this paper
• The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4

  1997cited by this paper
• Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores

  1997cited by this paper
• Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.

  1995cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT).

  1991cited by this paper
• Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

  1989influential reference
• Cytochrome P-450 immunolocalization in human liver.

  1986cited by this paper
• Fish consumption and mortality from coronary heart disease.

  1986cited by this paper
• Fish consumption and mortality from coronary heart disease.

  1985cited by this paper
• The inverse relation between fish consumption and 20-year mortality from coronary heart disease.

  1985cited by this paper

• Association Between Omega‐3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta‐Analysis of Randomized Controlled Trials

  2023cites this paper
• Effect Of Omega-3 Fatty Acids On Cardiovascular Protection- A Randomised Controlled Clinical Interventional Study

  2023cites this paper
• Polyunsaturated Fatty Acids: Impact on Health and Disease Status

  2021cites this paper
• Inhibition of Fatty Acid Metabolism Increases EPA and DHA Levels and Protects against Myocardial Ischaemia-Reperfusion Injury in Zucker Rats

  2021cites this paper
• Algal Derived Functional Lipids and their Role in Promoting Health

  2021cites this paper
• Reducing Bias in Public Health Guidelines

  2020cites this paper
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

  2020cites this paper
• Interaction between Statins and Omega 3 Poly-unsaturated Fatty Acids in Cardiovascular Disease: Synergistic or Not?

  2020cites this paper
• Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.

  2018cites this paper
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

  2018cites this paper
• Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia

  2018cites this paper
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

  2018cites this paper
• The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins

  2018cites this paper